Genzyme Flanders
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Belgium
- Registered address
- Cipalstraat 8, Geel, 2440, Belgium (BEL)
- Operations here
- analysisapi manufacturemanufacture
- FDA identifiers
- FEI 3003623839 · DUNS 372153895
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-09-25
- NAIDrug Quality Assurance2022-02-15
- NAIDrug Quality Assurance2018-03-23
- NAIDrug Quality Assurance2016-08-30
- NAIDrug Quality Assurance2016-03-22
- NAIDrug Quality Assurance2014-09-22
- VAIDrug Quality Assurance2013-11-22
- VAIDrug Quality Assurance2012-01-24
- VAIDrug Quality Assurance2011-10-27
Drugs this plant is listed as making
3 distinct drugs across 8 products name this site in their FDA label.
- Alglucosidase AlfaGenzyme Corporation
- Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtlBioverativ Therapeutics Inc.
- avalglucosidase alfa-ngptGenzyme Corporation
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.